WNT5A and neoplasm: Recent findings demonstrate that Wnt5a noncanonical ligand, as a tumor suppressor and oncogenic agent, can promote and inhibit tumor processes through canonical and noncanonical Wnt signaling in many common cancers such as colorectal breast, prostate, ovarian, bladder, and lung cancer [33, 34].